Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/10318
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Farouque, Omar | en |
dc.contributor.author | Meredith, Ian T | en |
dc.date.accessioned | 2015-05-15T23:44:03Z | |
dc.date.available | 2015-05-15T23:44:03Z | |
dc.date.issued | 2007-02-01 | en |
dc.identifier.citation | Trends in Cardiovascular Medicine; 17(2): 63-8 | en |
dc.identifier.govdoc | 17292049 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/10318 | en |
dc.description.abstract | The ATP-sensitive potassium (K(ATP)) channel is a distinct type of potassium ion channel that is found in the vascular smooth muscle cells of a variety of mammalian species, including humans. The activity of K(ATP) channels is determined by many factors including cellular ATP and ADP levels, thus providing a link between cellular metabolism and vascular tone through its effects on membrane potential. Experimental studies using inhibitors of K(ATP) channels, such as the sulfonuylurea class of drugs, indicate that these channels modulate coronary vascular tone including the hyperaemia induced by increased myocardial metabolism. This review examines the evidence linking K(ATP) channels to the regulation of coronary vascular tone and the potential clinical implications of pharmacologic therapies that act on K(ATP) channels. | en |
dc.language.iso | en | en |
dc.subject.other | Adenosine Triphosphate.physiology | en |
dc.subject.other | Animals | en |
dc.subject.other | Coronary Disease.drug therapy.physiopathology | en |
dc.subject.other | Coronary Vessels.drug effects.physiology.physiopathology | en |
dc.subject.other | Humans | en |
dc.subject.other | Muscle, Smooth, Vascular.drug effects.physiology | en |
dc.subject.other | Potassium Channel Blockers.pharmacology | en |
dc.subject.other | Potassium Channels.physiology | en |
dc.subject.other | Vasodilation.drug effects.physiology | en |
dc.title | Effect of adenosine triphosphate-sensitive potassium channel inhibitors on coronary metabolic vasodilation. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Trends in cardiovascular medicine | en |
dc.identifier.affiliation | Department of Cardiology, Austin Health, Heidelberg, Victoria, 3084, Australia | en |
dc.identifier.doi | 10.1016/j.tcm.2006.12.003 | en |
dc.description.pages | 63-8 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/17292049 | en |
dc.type.austin | Journal Article | en |
local.name.researcher | Farouque, Omar | |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.openairetype | Journal Article | - |
crisitem.author.dept | Cardiology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.